James R. Gorman, M.D., Ph.D. is a biopharma executive and serial entrepreneur, currently serving as Strategic Advisor to Agenus, and as Director of 180 Therapeutics. At Agenus, a publicly traded immune-oncology company, Dr. Gorman recently served as VP of Corporate Development and Strategy, assuming responsibilities of acting COO, including partnering and funding strategy, portfolio management processes, and strategic and operational alignment across functions. Previously, he was CEO and co-founder of two biotech startups, 121 Bio and BioAssets Development. 121 Bio, an immune-oncology focused company, was acquired by Agenus in 2016, and BioAssets Development, a company developing antibody-based anti-inflammatory therapies for disk herniation and sciatica, was acquired by Cephalon in 2010.
Previously, Dr. Gorman spent seven years in licensing, acquisitions, portfolio management and strategic initiatives at Abbott Laboratories (now Abbvie). He received the Abbott President’s Award for his role in initiating, championing and executing the 2001 acquisition of the blockbuster anti-TNF antibody Humira® and the fully human antibody platform in Abbott’s $7 billion acquisition of BASF Pharmaceuticals. Humira is now the top-selling drug, with annual sales of over $14 billion in 2015. Dr. Gorman formed and led Abbott’s Antibody Strategy Team through a series of licensing and acquisition transactions to expand Abbott’s biologics discovery technology platform and pipeline. He also co-chaired the Portfolio Management Committee. In this role, he initiated and oversaw a new targets and new projects process that led to the launch of ten new inflammation and oncology discovery projects.
Dr. Gorman obtained his M.D. and Ph.D. degrees in the Harvard Medical School M.D.-Ph.D. Program, conducting research in antibody molecular genetics in the lab of Dr. Frederick Alt, and graduated summa cum laude from Yale University with B.A. and M.S. degrees in biology. He currently serves on the Endowment Committee for The Eliot Church of South Natick, and enjoys skiing, bicycling and travel with family and friends.